Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00459953 · ClinicalTrials.gov registry record · Phase 2
Extended Cessation Treatment for Teen Smokers
A Phase 2 study of Nicotine Dependence, sponsored by Stanford University.
- Completed
- Registry status
- Phase 2
- Development phase
- 141
- Enrollment target
- 1
- Study location
NCT00459953 is a Phase 2 study of Nicotine Dependence that has completed, run by Stanford University. The registered enrollment target is 141 participants, below the 185-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00459953, a Phase 2 study of Nicotine Dependence, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 141 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed to test the efficacy of an extended smoking cessation program for teen smokers. We hypothesize that teen smokers randomized to extended treatment will have a higher abstinence rate at 52 week follow-up than teen smokers receiving only open label treatment.
Conditions Studied
Interventions
- DRUG Extended treatment
Study Locations (1)
California
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 141 participants |
| Start Date | 2006-09 |
| Est. Completion | 2011-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00459953
The ClinicalTrials.gov registry entry for NCT00459953 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 141 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 185-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (24% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Nicotine Dependence appearing as the primary indexed condition, and to 1 intervention - of which Extended treatment is the first listed.
NCT00459953 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00459953 about?
NCT00459953 is a clinical study titled "Extended Cessation Treatment for Teen Smokers". This study is designed to test the efficacy of an extended smoking cessation program for teen smokers. We hypothesize that teen smokers randomized to extended treatment will have a higher abstinence rate at 52 week follow-up than teen smokers receiving only open label treatment.
What is the current status of trial NCT00459953?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 141 participants. The study started on 2006-09. Estimated completion is 2011-07.
What conditions does trial NCT00459953 study?
This clinical trial studies the following conditions: Nicotine Dependence.
What interventions are being tested in trial NCT00459953?
The interventions under investigation include: Extended treatment (DRUG).
Who is sponsoring clinical trial NCT00459953?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00459953 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nicotine Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Trial of Varenicline for E-cigarette Cessation
RECRUITING · Phase 2
-
Menstrual Cycle Effects on Smoking Cessation and Cue Reactivity
COMPLETED · Phase 2
-
N-acetylcysteine for Tobacco Use Disorder
COMPLETED · Phase 2
-
Targeted Interventions for Weight-Concerned Smokers
COMPLETED · Phase 2
-
Adaptive Pharmacotherapy for Smoking Cessation
COMPLETED · Phase 2
-
E-cigarette Nicotine Study
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.